Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CRISPR/CAS-related methods and compositions for treating cystic fibrosis

CRISPR/CAS-related methods and compositions for treating cystic fibrosis

US Patent 11028394 · Granted Jun 8, 2021

Estimated economic value: $16,308,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crispr/CAS-related methods and compositions for treating primary open angle glau2025
Crispr/CAS-related methods and compositions for treating primary open angle glau2025
CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated usher syndrome2025
Modulation of gene transcription using antisense oligonucleotides targeting regu2025
Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and s2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
TAL-Tet1 fusion proteins and methods of use thereof2024
Phenothiazine derivatives and uses thereof2024
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific g2024
GNAQ targeted dsRNA compositions and methods for inhibiting expression2024
Transcription activator-like effector (tale) - lysine-specific demethylase 1 (LS2024